XETRA - Delayed Quote EUR

Fresenius SE & Co. KGaA (FRE.DE)

27.75 -0.19 (-0.68%)
As of 5:35 PM GMT+2. Market Open.
Loading Chart for FRE.DE
DELL
  • Previous Close 27.94
  • Open 28.01
  • Bid 27.77 x --
  • Ask 27.78 x --
  • Day's Range 27.72 - 28.05
  • 52 Week Range 23.93 - 31.22
  • Volume 591,829
  • Avg. Volume 1,167,167
  • Market Cap (intraday) 15.63B
  • Beta (5Y Monthly) 1.05
  • PE Ratio (TTM) 44.05
  • EPS (TTM) 0.63
  • Earnings Date Jul 31, 2024
  • Forward Dividend & Yield 0.92 (3.19%)
  • Ex-Dividend Date May 18, 2023
  • 1y Target Est 35.60

Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, dialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients. This segment offers I.V. generic drugs; biosimilar drugs for autoimmune diseases and oncology; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment provides clinical and nursing care facilities. The Fresenius Vamed segment provides services for hospitals and other healthcare facilities. This segment also offers operational management of healthcare facilities and provides services to patients. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.

www.fresenius.com

190,863

Full Time Employees

December 31

Fiscal Year Ends

Recent News: FRE.DE

Performance Overview: FRE.DE

Trailing total returns as of 5/20/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

FRE.DE
1.14%
DAX PERFORMANCE-INDEX
12.04%

1-Year Return

FRE.DE
0.95%
DAX PERFORMANCE-INDEX
15.32%

3-Year Return

FRE.DE
32.17%
DAX PERFORMANCE-INDEX
24.19%

5-Year Return

FRE.DE
35.86%
DAX PERFORMANCE-INDEX
53.35%

Compare To: FRE.DE

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: FRE.DE

Valuation Measures

Annual
As of 5/17/2024
  • Market Cap

    15.74B

  • Enterprise Value

    29.28B

  • Trailing P/E

    44.35

  • Forward P/E

    9.47

  • PEG Ratio (5yr expected)

    0.27

  • Price/Sales (ttm)

    0.71

  • Price/Book (mrq)

    0.83

  • Enterprise Value/Revenue

    1.31

  • Enterprise Value/EBITDA

    10.74

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -2.95%

  • Return on Assets (ttm)

    1.26%

  • Return on Equity (ttm)

    0.75%

  • Revenue (ttm)

    22.46B

  • Net Income Avi to Common (ttm)

    312M

  • Diluted EPS (ttm)

    0.63

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.02B

  • Total Debt/Equity (mrq)

    72.10%

  • Levered Free Cash Flow (ttm)

    2.97B

Research Analysis: FRE.DE

Company Insights: FRE.DE

Research Reports: FRE.DE

People Also Watch